## Analysis of NVBDCP Statements ### Correct Statements (Options 0, 1, 3) **Option 0 — Malaria Surveillance:** - India's IDSS mandates reporting of all confirmed malaria cases - Surveillance data drives targeted interventions and resource allocation - This is a core NVBDCP function **Option 1 — Dengue Vector Control:** - Aedes aegypti is the primary vector for dengue in India - Source reduction (eliminating stagnant water, containers) is the cornerstone of prevention - Chemical spraying (space spray, fogging) is used during outbreaks - Both methods are integral to NVBDCP dengue strategy **Option 3 — Malaria Treatment:** - ACT (artemether-lumefantrine, artesunate-amodiaquine) is the WHO-recommended and India-adopted first-line for uncomplicated P. falciparum malaria - This aligns with NVBDCP treatment guidelines ### Incorrect Statement (Option 2) — Why It Is Wrong **Key Point:** The target year for lymphatic filariasis elimination in India was **2015**, NOT 2020. This deadline has already passed. **High-Yield:** India declared lymphatic filariasis **eliminated as a public health problem in 2019** after achieving the WHO elimination threshold (microfilaremia prevalence <1% in all endemic districts). The NVBDCP's original 2015 target was revised, but the statement's claim of "2020" is factually incorrect and outdated. **Clinical Pearl:** While DEC and albendazole remain the drugs of choice for mass drug administration (MDA) in filariasis, the timeline cited in Option 2 does not reflect actual NVBDCP milestones. ### Summary Table | Statement | Status | Reason | |-----------|--------|--------| | IDSS surveillance for malaria | Correct | Mandatory reporting system in place | | Dengue vector control (Aedes) | Correct | Source reduction + chemical spray | | Filaria elimination by 2020 | **INCORRECT** | Target was 2015; declared eliminated 2019 | | ACT for P. falciparum | Correct | First-line NVBDCP guideline |
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.